In April the world's first Marijuana Exchange Traded Fund, Horizon Medical Marijuana Life Sciences ETF (TSE:HMMJ) hit the public markets. The ETF went public at $10 per share and popped during its first few days of trading.
When HMMJ hit the public markets, investors were craving exposure to marijuana stocks as new laws and regulations have helped push marijuana into the mainstream spotlight. Some U.S. states and parts of Canada have decriminalized the drug while it has spread in popularity and acceptance for its medical use.
HMMJ has traded as high as $23 per share since going public, but currently, it is below its Initial Public Offering price, trading at $9.36 per share. So what is happening and is it worth investing in the industry today? Continue reading "Should You Be Investing In Marijuana"
Analysis originally distributed on May 10, 2017 By: Michael Vodicka of Cannabis Stock Trades
If you like getting a good deal then once again the time has come to take a look at cannabis stocks.
The cannabis sector has fallen into a bear market. A bear market happens when a stock falls 20% or more from its 52-week high.
After posting massive gains in 2016 and early 2017 – the MJIC Index North American Cannabis Index is down 25% from its 52-week high. Take a look.
I don’t see any fundamental reason for the pullback. As always there has been plenty of good news coming out of the cannabis industry. Continue reading "First Ever Cannabis ETF: Friend or Foe?"
The Horizons Medical Marijuana Life Sciences ETF (HMMJ) will begin trading on the Toronto Stock Exchange today, April 5th 2017. This will be the first ETF that will have exposure to companies listed in North America that operate in the medical marijuana bioengineering and production fields.
Many investors have been interested in the industry for a number of years, but haven't had the opportunity to invest in it through a diversified manner. This ETF solves that big hurdle.
While it is unknown how many stocks the fund will hold, or who exactly will be in it, investors can be assured this ETF boasts some very serious growth predictions. Sales in the marijuana industry grew by 30% in 2016 and according to Arcview Market Research; the industry will triple in the next four years. Continue reading "Will You Buy A Marijuana ETF?"
As more and more states either allow medical marijuana to be sold or outright legalize the drug, investors interests in the business of marijuana have grown. Countless outfits have popped up on the public markets, mainly on the OTC or over the counter exchange, touting the idea that they will be the next big marijuana conglomerate which will dominate sales of the drug throughout the US.
This 'possible' market opportunity for marijuana based companies in the US could be rather large, if all 52 states opened their doors to the drug by making it legal. (Just thinking about this idea makes dollar signs pop into my head.) But as of now, the business is still small, with only a few states completely legalizing the drug and just a few others allowing it to be used for medical reasons. Continue reading "Will there be a Marijuana ETF in 2015?"